Esophageal Diseases Global Clinical Trials Review, H1, 2015

Esophageal Diseases Global Clinical Trials Review, H1, 2015


  • Products Id :- GDHC2675CTIDB
  • |
  • Pages: 103
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Esophageal Diseases Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Esophageal Diseases Global Clinical Trials Review, H1, 2015" provides data on the Esophageal Diseases clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Esophageal Diseases. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Esophageal Diseases. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each

Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons To Buy

Understand the dynamics of a particular indication in a condensed manner

Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

Obtain discontinued trial listing for trials across the globe

Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Esophageal Diseases 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Five Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Esophageal Diseases to Gastrointestinal Clinical Trials 15

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Esophageal Diseases to Gastrointestinal Clinical Trials 18

Clinical Trials by Phase in E7 Countries 19

Clinical Trials in E7 Countries by Trial Status 20

Clinical Trials by Phase 21

In Progress Trials by Phase 22

Clinical Trials by Trial Status 23

Clinical Trials by End Point Status 24

Unaccomplished Trials of Esophageal Diseases 25

Subjects Recruited Over a Period of Time 30

Clinical Trials by Sponsor Type 31

Prominent Sponsors 32

Top Companies Participating in Esophageal Diseases Therapeutics Clinical Trials 33

Prominent Drugs 34

Clinical Trial Profiles 35

Clinical Trial Overview of Top Companies 35

AstraZeneca PLC 35

Clinical Trial Overview of AstraZeneca PLC 35

Takeda Pharmaceutical Company Limited 43

Clinical Trial Overview of Takeda Pharmaceutical Company Limited 43

Eisai Co., Ltd. 49

Clinical Trial Overview of Eisai Co., Ltd. 49

Johnson & Johnson 52

Clinical Trial Overview of Johnson & Johnson 52

Pfizer Inc. 54

Clinical Trial Overview of Pfizer Inc. 54

Indivior PLC 56

Clinical Trial Overview of Indivior PLC 56

Novartis AG 58

Clinical Trial Overview of Novartis AG 58

Shire Plc 59

Clinical Trial Overview of Shire Plc 59

Yuhan Corporation 60

Clinical Trial Overview of Yuhan Corporation 60

Dr. Reddy's Laboratories Limited 61

Clinical Trial Overview of Dr. Reddy's Laboratories Limited 61

Clinical Trial Overview of Top Institutes / Government 62

Mayo Clinic 62

Clinical Trial Overview of Mayo Clinic 62

Shimane University 63

Clinical Trial Overview of Shimane University 63

Academic Medical Center 64

Clinical Trial Overview of Academic Medical Center 64

The University of Utah 65

Clinical Trial Overview of The University of Utah 65

Zhongshan Hospital 66

Clinical Trial Overview of Zhongshan Hospital 66

Chinese University of Hong Kong 67

Clinical Trial Overview of Chinese University of Hong Kong 67

Cincinnati Children's Hospital Medical Center 68

Clinical Trial Overview of Cincinnati Children's Hospital Medical Center 68

Department of Health, UK 69

Clinical Trial Overview of Department of Health, UK 69

Hyogo College Of Medicine 70

Clinical Trial Overview of Hyogo College Of Medicine 70

Juntendo University School of Medicine 71

Clinical Trial Overview of Juntendo University School of Medicine 71

Five Key Clinical Profiles 72

Appendix 101

Abbreviations 101

Definitions 101

Research Methodology 102

Secondary Research 102

About GlobalData 103

Contact Us 103

Disclaimer 103

Source 103

List of Figures

Esophageal Diseases Therapeutics, Global, Clinical Trials by Region (%), 2015* 7

Esophageal Diseases Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Esophageal Diseases Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Esophageal Diseases Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10

Esophageal Diseases Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11

Esophageal Diseases Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12

Esophageal Diseases Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015* 13

Esophageal Diseases Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015* 14

Proportion of Esophageal Diseases to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 15

Esophageal Diseases Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Esophageal Diseases Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Esophageal Diseases to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 18

Esophageal Diseases Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Esophageal Diseases Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Esophageal Diseases Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21

Esophageal Diseases Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22

Esophageal Diseases Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Esophageal Diseases Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Esophageal Diseases Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 30

Esophageal Diseases Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 31

Esophageal Diseases Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 32

Esophageal Diseases Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 33

Esophageal Diseases Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 34

GlobalData Methodology 102

List of Tables

Esophageal Diseases Therapeutics, Global, Clinical Trials by Region, 2015* 7

Esophageal Diseases Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Esophageal Diseases Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Esophageal Diseases Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10

Esophageal Diseases Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11

Esophageal Diseases Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Esophageal Diseases Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015* 13

Esophageal Diseases Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015* 14

Proportion of Esophageal Diseases to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 15

Esophageal Diseases Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Esophageal Diseases Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Esophageal Diseases to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 18

Esophageal Diseases Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Esophageal Diseases Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Esophageal Diseases Therapeutics, Global, Clinical Trials by Phase, 2015* 21

Esophageal Diseases Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22

Esophageal Diseases Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Esophageal Diseases Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Esophageal Diseases Therapeutics, Global, Suspended Clinical Trials, 2015* 25

Esophageal Diseases Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26

Esophageal Diseases Therapeutics, Global, Terminated Clinical Trials, 2015* 27

Esophageal Diseases Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 30

Esophageal Diseases Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 31

Esophageal Diseases Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 32

Esophageal Diseases Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 33

Esophageal Diseases Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 34

Esophageal Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2015* 35

Esophageal Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2015* 43

Esophageal Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2015* 49

Esophageal Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2015* 52

Esophageal Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 54

Esophageal Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by Indivior PLC, 2015* 56

Esophageal Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 58

Esophageal Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by Shire Plc, 2015* 59

Esophageal Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by Yuhan Corporation, 2015* 60

Esophageal Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by Dr. Reddy's Laboratories Limited, 2015* 61

Esophageal Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2015* 62

Esophageal Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by Shimane University, 2015* 63

Esophageal Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Center, 2015* 64

Esophageal Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Utah, 2015* 65

Esophageal Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by Zhongshan Hospital, 2015* 66

Esophageal Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by Chinese University of Hong Kong, 2015* 67

Esophageal Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by Cincinnati Children's Hospital Medical Center, 2015* 68

Esophageal Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by Department of Health, UK, 2015* 69

Esophageal Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by Hyogo College Of Medicine, 2015* 70

Esophageal Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by Juntendo University School of Medicine, 2015* 71

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

AstraZeneca PLC

Takeda Pharmaceutical Company Limited

Eisai Co., Ltd.

Johnson & Johnson

Pfizer Inc.

Indivior PLC

Novartis AG

Shire Plc

Yuhan Corporation

Dr. Reddy's Laboratories Limited

Esophageal Diseases Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Esophageal Diseases, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.

select a license

Single User License
USD 2500 INR 160900
Site License
USD 5000 INR 321800
Corporate User License
USD 7500 INR 482700

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com